From virtual reality anxiety treatments to notifications delivered to a healthcare professional after a patient swallows a pill, could the future of pharma be a drop in the ocean of the world of science fiction? Not necessarily.
Throughout 2020, the medical and pharmaceutical community have learnt to accept and appreciate digitization. With that in mind, manufacturing and delivering drugs to the community will become a much more inclusive process. Here are some of the top trends for 2021.
- Patients are part of the journey:
For the first time in history, patients are much more involved in their treatment processes. Their position in the hierarchy is not only a consumer but also as an equal partner in the pharma sector. By incorporating their point of view, pharmaceuticals will be able to develop new products with greater ease.
- Post pill engagement:
Developing a drug and feeding it to patients is not enough any more. Pharmaceuticals should strive to engage with patients even after their drug is consumed through digital apps, devices, or services introduced to the patient by the doctor.
- Sense of the environment:
Nanotechnology has grown leaps and bounds since its inception. Incorporating soluble, digestible sensors in pills could help health professionals track the efficacy of medicines they prescribe after their patients swallow them. Back in 2015, the FDA approved a drug product combined with a digestible sensor. The data gathered from the sensor is sent to the caretaker or the patient himself.
- Test drugs virtually:
Drug approval processes are lengthy and expensive procedures, mainly because they involve trials on a large number of people during the process of development. By testing through something known as a silico trial, a computer simulation that tests drugs and devices, we could cut down trial times exponentially. HumMod is an example of such a simulation.
It provides a top-down model of human physiology from whole organs to individual molecules. It aims to simulate how human physiology works and claims to be the most sophisticated mathematical model of human physiology ever created.
- Engage medical practitioners:
Augmented and Virtual Realities have opened a world of opportunities in the pharmaceutical sector. Creating more engaging medical communication could help practitioners make quicker decisions regarding adopting new drugs and introducing new treatments.
With such a versatile list of developments in the pharmaceutical sector, 2021 promises to be extremely exciting. Digital health is here to stay, and it’s time to welcome (and embrace) the change.
Discover how Ethosh can help you make the most of 2021 with our range of solutions for the pharmaceutical sector. Reach out to us here.
Don’t forget to follow us on LinkedIn and Facebook for more updates.